Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China.

by Shuyan Gu, Yuhang Zeng, Demin Yu, Xiaoqian Hu, Hengjin Dong
Published 2016-01-01

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China.

by Shuyan Gu, Yiming Mu, Suodi Zhai, Yuhang Zeng, Xuemei Zhen, Hengjin Dong
Published 2016-01-01

A Resources-Efficient Configurable Accelerator for Deep Convolutional Neural Networks

by Xianghong Hu, Yuhang Zeng, Zicong Li, Xin Zheng, Shuting Cai, Xiaoming Xiong
Published 2019-01-01

The Quality of Caregivers for the Elderly in Long-Term Care Institutions in Zhejiang Province, China

by Yuhang Zeng, Xiaoqian Hu, Yuanyuan Li, Xuemei Zhen, Yuxuan Gu, Xueshan Sun, Hengjin Dong
Published 2019-06-01

Chinese Minority Perceives the Doctor-Patient Relationship Differently: A Cultural and Economic Interpretation

by Qian Yang, Qian Yang, Hao Zhang, Mengfei Yu, Xiaoqian Hu, Yuxuan Gu, Xueshan Sun, Xuemei Zhen, Shuyan Gu, Minzhuo Huang, Jingming Wei, Yuhang Zeng, Hengjin Dong, Hengjin Dong
Published 2019-11-01